These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 23945587)

  • 1. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.
    Yang L; Lin C; Jin C; Yang JC; Tanasa B; Li W; Merkurjev D; Ohgi KA; Meng D; Zhang J; Evans CP; Rosenfeld MG
    Nature; 2013 Aug; 500(7464):598-602. PubMed ID: 23945587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo.
    Pestell RG; Yu Z
    Asian J Androl; 2014; 16(2):268-9. PubMed ID: 24435053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
    Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD
    Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long noncoding RNA connects c-Myc to tumor metabolism.
    Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer.
    Prensner JR; Sahu A; Iyer MK; Malik R; Chandler B; Asangani IA; Poliakov A; Vergara IA; Alshalalfa M; Jenkins RB; Davicioni E; Feng FY; Chinnaiyan AM
    Oncotarget; 2014 Mar; 5(6):1434-8. PubMed ID: 24727738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.
    Decker KF; Zheng D; He Y; Bowman T; Edwards JR; Jia L
    Nucleic Acids Res; 2012 Nov; 40(21):10765-79. PubMed ID: 23019221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.
    Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D
    Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer.
    Zhang A; Zhao JC; Kim J; Fong KW; Yang YA; Chakravarti D; Mo YY; Yu J
    Cell Rep; 2015 Oct; 13(1):209-221. PubMed ID: 26411689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation.
    Sen A; De Castro I; Defranco DB; Deng FM; Melamed J; Kapur P; Raj GV; Rossi R; Hammes SR
    J Clin Invest; 2012 Jul; 122(7):2469-81. PubMed ID: 22684108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells.
    Misawa A; Takayama K; Urano T; Inoue S
    J Biol Chem; 2016 Aug; 291(34):17861-80. PubMed ID: 27342777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance.
    Li S; Hu MG; Sun Y; Yoshioka N; Ibaragi S; Sheng J; Sun G; Kishimoto K; Hu GF
    Mol Cancer Res; 2013 Oct; 11(10):1203-14. PubMed ID: 23851444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
    Kregel S; Kiriluk KJ; Rosen AM; Cai Y; Reyes EE; Otto KB; Tom W; Paner GP; Szmulewitz RZ; Vander Griend DJ
    PLoS One; 2013; 8(1):e53701. PubMed ID: 23326489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of androgen receptor splice variant AR3 by PCGEM1.
    Zhang Z; Zhou N; Huang J; Ho TT; Zhu Z; Qiu Z; Zhou X; Bai C; Wu F; Xu M; Mo YY
    Oncotarget; 2016 Mar; 7(13):15481-91. PubMed ID: 26848868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
    Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.
    Peacock SO; Fahrenholtz CD; Burnstein KL
    Mol Endocrinol; 2012 Dec; 26(12):1967-79. PubMed ID: 23023561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
    Kasina S; Macoska JA
    Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.
    Hu R; Lu C; Mostaghel EA; Yegnasubramanian S; Gurel M; Tannahill C; Edwards J; Isaacs WB; Nelson PS; Bluemn E; Plymate SR; Luo J
    Cancer Res; 2012 Jul; 72(14):3457-62. PubMed ID: 22710436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.
    Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S
    Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.
    Toropainen S; Niskanen EA; Malinen M; Sutinen P; Kaikkonen MU; Palvimo JJ
    Sci Rep; 2016 Sep; 6():33510. PubMed ID: 27641228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.